Medicine and Dentistry
Infection
100%
Diseases
51%
Intensive Care Unit
49%
Pathogen
41%
Osteomyelitis
36%
Meningitis
33%
Antiinfective Agent
30%
Gram-Negative Bacteria
30%
Immunocompromised Patient
30%
Staphylococcus Aureus
19%
Antibiotic Resistance
19%
Hospital Infection
17%
Human Immunodeficiency Virus
16%
Leeching
16%
Ménière's Disease
16%
Endarteritis
16%
Xenotropic MuLV Related Virus
16%
Strongyloides
16%
Skin Nodule
16%
Immunoglobulin
16%
Actinomyces
16%
Strongyloidiasis
16%
Urinary Diversion
16%
Headache
16%
Diplopia
16%
Finger
16%
Brain Abscess
16%
Angioplasty
16%
Infection Prevention
16%
Diskitis
16%
Aeromonas
16%
Endocarditis
16%
Sucralfate
16%
Hemodialysis
16%
Joint Injection
16%
Human Immunodeficiency Virus Infection
16%
Campylobacter Enteritis
16%
Gram Negative Sepsis
16%
Epidural Abscess
16%
Low Back Pain
16%
Travel Related Disease
16%
Femoral Artery
16%
Orthopedics
16%
Hepatitis C Virus
16%
Oropharynx
16%
Bacterial Infection
16%
Infection Control
16%
Broad-Spectrum Antibiotic
16%
Mycosis
16%
Mycobacterial Infection
16%
Keyphrases
Intensive Care Unit
49%
Pharmacokinetics
37%
Meningitis
33%
Tenosynovitis
30%
Vancomycin-resistant Enterococci
24%
Selective Decontamination
24%
Pneumonia
24%
Rheumatologists
22%
Prophylactic Antibiotics
19%
Clinical Course
19%
Ciprofloxacin
19%
Steady State
18%
Gram-negative Bacilli
18%
Enfuvirtide
18%
HIV Infection
18%
Nosocomial Infection
17%
Fever
16%
Ugandan
16%
Intrapartum
16%
Cryptococcal Osteomyelitis
16%
Nevirapine
16%
Travel-related Illness
16%
Febrile Neutropenia
16%
Endarteritis
16%
Empirical Therapy
16%
Gram-negative Bacteremia
16%
Amikacin
16%
Neutropenic Patients
16%
Human Immunodeficiency Virus Type 1 (HIV-1)
16%
Multicenter Randomized Trial
16%
Azlocillin
16%
Pharmacokinetics-pharmacodynamics (PK-PD)
16%
Endolymphatic Hydrops
16%
Campylobacter Jejuni Infection
16%
Native Valve Endocarditis
16%
Single Center
16%
Once-daily
16%
Xenotropic murine Leukemia Virus-related Virus
16%
Adult Immunization
16%
Solid Organ Transplant Recipients
16%
Street Medicine
16%
Houselessness
16%
Antibiotic Use
16%
Quinupristin-dalfopristin
16%
HIV Patients
16%
Femoral Artery
16%
Bacterial Infection
16%
Mycobacterium Terrae Complex
16%
Angioplasty
16%
Mycobacterium Arupense
16%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
69%
Pharmacokinetics
49%
HIV
33%
Gram Negative Bacterium
28%
Antibiotics
22%
Diseases
22%
Tenosynovitis
22%
Mycobacteria
22%
Infectious Agent
19%
Enfuvirtide
18%
Cohort Study
16%
Pharmacodynamics
16%
Enterococcus faecium
16%
Nevirapine
16%
Legionella
16%
Cytomegalovirus Infection
16%
Dalfopristin Plus Quinupristin
16%
Vancomycin-Resistant Enterococcus
16%
Candidiasis
16%
Amikacin
16%
Azlocillin
16%
Ganciclovir
16%
Voriconazole
16%
Ciprofloxacin
16%
Endocarditis
16%
Sucralfate
16%
Bacterial Infection
16%
Gram Negative Sepsis
16%
Hemodialysis
16%
Antibiotic Therapy
15%
Cytomegalovirus
12%
Bloodstream Infection
11%
Mycobacterium Terrae Complex
11%
Stress Ulcer
11%
Tumor Necrosis Factor Inhibitor
11%
Cefotaxime
8%
Polymyxin
7%
Nystatin
7%
Gentamicin
7%
Infection Rate
6%
Ampicillin
6%
Adverse Event
5%
Duck
5%
Bioaerosol
5%
Bone and Joint Infections
5%
Histamine
5%
Lung Infection
5%
Antacid Agent
5%
Rheumatic Disease
5%
Nucleic Acid
5%
